A detailed history of Nisa Investment Advisors, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 42,938 shares of NEO stock, worth $598,555. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42,938
Previous 42,832 0.25%
Holding current value
$598,555
Previous $673,000 11.59%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$13.01 - $15.77 $1,379 - $1,671
106 Added 0.25%
42,938 $595,000
Q1 2024

May 01, 2024

BUY
$14.06 - $16.79 $1,518 - $1,813
108 Added 0.25%
42,832 $673,000
Q3 2023

Nov 02, 2023

SELL
$12.15 - $17.85 $114,210 - $167,790
-9,400 Reduced 18.03%
42,724 $525,000
Q4 2022

Feb 02, 2023

BUY
$6.45 - $12.07 $16,125 - $30,175
2,500 Added 5.04%
52,124 $482,000
Q3 2022

Nov 07, 2022

BUY
$7.86 - $12.91 $190,125 - $312,279
24,189 Added 95.1%
49,624 $373,000
Q2 2022

Aug 03, 2022

BUY
$7.06 - $13.97 $35,300 - $69,850
5,000 Added 24.47%
25,435 $207,000
Q1 2022

Apr 29, 2022

SELL
$12.15 - $35.28 $6,075 - $17,640
-500 Reduced 2.39%
20,435 $248,000
Q4 2021

Feb 03, 2022

BUY
$30.49 - $48.49 $141,473 - $224,993
4,640 Added 28.47%
20,935 $472,000
Q3 2021

Oct 18, 2021

SELL
$41.66 - $52.52 $99,692 - $125,680
-2,393 Reduced 12.81%
16,295 $786,000
Q4 2020

Jan 25, 2021

BUY
$36.08 - $56.47 $538,963 - $843,548
14,938 Added 398.35%
18,688 $1.01 Million
Q3 2020

Oct 20, 2020

BUY
$33.26 - $40.48 $79,824 - $97,151
2,400 Added 177.78%
3,750 $138,000
Q2 2020

Jul 27, 2020

SELL
$24.21 - $31.02 $79,166 - $101,435
-3,270 Reduced 70.78%
1,350 $42,000
Q1 2020

Apr 17, 2020

BUY
$20.5 - $34.53 $15,375 - $25,897
750 Added 19.38%
4,620 $128,000
Q3 2019

Oct 17, 2019

BUY
$19.12 - $26.24 $66,346 - $91,052
3,470 Added 867.5%
3,870 $74,000
Q1 2019

Apr 17, 2019

BUY
$12.14 - $20.46 $4,856 - $8,184
400 New
400 $8,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.75B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.